Cargando…
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
There is an urgent need for reliable high-throughput serological assays for the management of the ongoing COVID-19 pandemic. Preferably, the performance of serological tests for a novel virus should be determined with clinical specimens against a gold standard, i.e. virus neutralisation. We compared...
Autores principales: | Jääskeläinen, AJ, Kuivanen, S, Kekäläinen, E, Ahava, MJ, Loginov, R, Kallio-Kokko, H, Vapalahti, O, Jarva, H, Kurkela, S, Lappalainen, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295517/ https://www.ncbi.nlm.nih.gov/pubmed/32563180 http://dx.doi.org/10.1016/j.jcv.2020.104512 |
Ejemplares similares
-
Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection
por: Ahava, M.J., et al.
Publicado: (2022) -
Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022) -
Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA
por: Mannonen, Laura, et al.
Publicado: (2021) -
Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples
por: Jääskeläinen, Anne J, et al.
Publicado: (2020) -
Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients
por: Kortela, Elisa, et al.
Publicado: (2021)